中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
1期
178-180,186
,共4页
鼻咽癌%调强放疗%不良反应%预防措施
鼻嚥癌%調彊放療%不良反應%預防措施
비인암%조강방료%불량반응%예방조시
Nasopharyngeal carcinoma%Intensity modulated radiation therapy%Adverse reactions%Preventive measures
目的:对鼻咽癌调强放疗相关不良反应的预防及处理措施进行探讨,提高放疗期间的安全性。方法选取我院2011年2月~2013年5月收治的80例接受调强放疗的鼻咽癌患者,按照入院顺序分为干预组与对照组各40例,干预组给予不良反应预防措施,对照组不给予相关措施,比较两组患者放疗中及治疗后的不良反应情况。结果干预组40例患者出现急性皮肤反应(0~2级)38例,消化道反应5例,骨髓抑制(3级)4例,口腔黏膜急性反应2例;对照组40例患者出现急性皮肤反应(0~3级)40例,消化道反应11例,骨髓抑制(3级)8例,口腔黏膜急性反应6例。干预组放疗期间不良反应发生率及程度均低于对照组( P<0.05),具有统计学意义。结论对鼻咽癌调强放疗患者实施相关预防措施可有效降低放疗期间不良反应发生率。
目的:對鼻嚥癌調彊放療相關不良反應的預防及處理措施進行探討,提高放療期間的安全性。方法選取我院2011年2月~2013年5月收治的80例接受調彊放療的鼻嚥癌患者,按照入院順序分為榦預組與對照組各40例,榦預組給予不良反應預防措施,對照組不給予相關措施,比較兩組患者放療中及治療後的不良反應情況。結果榦預組40例患者齣現急性皮膚反應(0~2級)38例,消化道反應5例,骨髓抑製(3級)4例,口腔黏膜急性反應2例;對照組40例患者齣現急性皮膚反應(0~3級)40例,消化道反應11例,骨髓抑製(3級)8例,口腔黏膜急性反應6例。榦預組放療期間不良反應髮生率及程度均低于對照組( P<0.05),具有統計學意義。結論對鼻嚥癌調彊放療患者實施相關預防措施可有效降低放療期間不良反應髮生率。
목적:대비인암조강방료상관불량반응적예방급처리조시진행탐토,제고방료기간적안전성。방법선취아원2011년2월~2013년5월수치적80례접수조강방료적비인암환자,안조입원순서분위간예조여대조조각40례,간예조급여불량반응예방조시,대조조불급여상관조시,비교량조환자방료중급치료후적불량반응정황。결과간예조40례환자출현급성피부반응(0~2급)38례,소화도반응5례,골수억제(3급)4례,구강점막급성반응2례;대조조40례환자출현급성피부반응(0~3급)40례,소화도반응11례,골수억제(3급)8례,구강점막급성반응6례。간예조방료기간불량반응발생솔급정도균저우대조조( P<0.05),구유통계학의의。결론대비인암조강방료환자실시상관예방조시가유효강저방료기간불량반응발생솔。
Objective To explore the prevention and treatment measures of related adverse reactions in intensity modulated radiation therapy for nasopharyngeal carcinoma, and improve the safety during the radiotherapy. Methods 80 cases with nasopharyngeal carcinoma who received the intensity modulated radiation therapy in our hospital from February 2011 to May 2013 were divided into the intervention group and the control group according to the order of admission, each group had 40 cases. The patients in the intervention group were given the preventive measures of adverse reactions, while the patients in the control group were not given the relevant measures, and the adverse reactions of patients in the two groups during and after the radiation therapy were compared. Results In 40 patients of the intervention group, there were 38 cases with acute skin reactions(0 ~ 2 grade), 5 cases with gastrointestinal reactions, 4 cases with bone marrow depression(3 grade), 2 cases with acute oral mucosa reactions; In 40 patients of the control group, there were 40 cases with acute skin reactions(0~3 grade), 11 cases with gastrointestinal reactions, 8 cases with bone marrow depression(3 grade), 6 cases with acute oral mucosa reactions. The incidence and degree of adverse reactions during the radiation therapy in the intervention group were lower than those in the control group (P < 0.05), and the differences were statistically significant. Conclusion The implementation of relevant preventive measures can effectively reduce the incidence of adverse reactions during the radiation therapy in patients with nasopharyngeal carcinoma receiving the intensity modulated radiation therapy.